Team Blue was led by Geoffrey Coley, CRI board member and international business head of MUFG Securities Holdings Co., Ltd. Geoffrey is the great-nephew of CRI’s founder, Helen Coley Nauts, and the great-grandson of Dr. William B. Coley, now recognized as the “Father of Cancer Immunotherapy.”
Japan’s MUFG kept its nose clean during the financial crisis. Then it cracked the U.S. market by offering clients an option outside the mega-banks....“We’re one of the few growth stories in an industry that is in secular decline,” says the securities group’s international business head, Geoffrey Coley, who started at MUFG Securities in June 2014 to help expand the business.
